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Leishmania parasites infect macrophages, causing a wide spectrum of human diseases, 
from cutaneous to visceral forms. In search of novel therapeutic targets, we performed 
comprehensive in vitro and ex vivo mapping of the signaling pathways upstream and 
downstream of antioxidant transcription factor [nuclear factor erythroid 2-related factor 
2 (Nrf2)] in cutaneous leishmaniasis (CL), by combining functional assays in human and 
murine macrophages with a systems biology analysis of in situ (skin biopsies) CL patient 
samples. First, we show the PKR pathway controls the expression and activation of 
Nrf2 in Leishmania amazonensis infection in vitro. Nrf2 activation also required PI3K/Akt 
signaling and autophagy mechanisms. Nrf2- or PKR/Akt-deficient macrophages exhib-
ited increased levels of ROS/RNS and reduced expression of Sod1 Nrf2-dependent 
gene and reduced parasite load. L. amazonensis counteracted the Nrf2 inhibitor Keap1 
through the upregulation of p62 via PKR. This Nrf2/Keap1 observation was confirmed 
in situ in skin biopsies from Leishmania-infected patients. Next, we explored the ex vivo 
transcriptome in CL patients, as compared to healthy controls. We found the antioxidant 
response element/Nrf2 signaling pathway was significantly upregulated in CL, including 
downstream target p62. In silico enrichment analysis confirmed upstream signaling by 
interferon and PI3K/Akt, and validated our in vitro findings. Our integrated in vitro, ex vivo, 
and in silico approach establish Nrf2 as a central player in human cutaneous leishmaniasis 
and reveal Nrf2/PKR crosstalk and PI3K/Akt pathways as potential therapeutic targets.
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inTrODUcTiOn
Human cutaneous leishmaniasis (CL) is spread worldwide, and the incidence is estimated to be from 
0.7 to 1.2 million cases each year (1). Different clinical manifestations occur in humans due to the 
immune response and the infection by distinct Leishmania species (2). Leishmania parasites exhibit 
a plethora of adaptive mechanisms that interfere with several macrophage functions through the 
manipulation of host signaling pathways (3).
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The imbalance between oxidative stress and cytoprotective 
systems of detoxification dictates the outcome of intracellular 
parasitic infections (4). The transcription factor [nuclear factor 
erythroid 2-related factor 2 (Nrf2)] is a master regulator of 
phase II defense gene expression that may protect cells from 
oxidative stress. The DNA promoter sequences of phase II 
defense genes share the canonical antioxidant response ele-
ment (ARE), which is recognized by Nrf2 (5). Nrf2-dependent 
expression leads to profound effects on the suppression of the 
inflammatory response and immune activation through Toll-
like receptors (6, 7).
The control of Nrf2 activation is dictated by different post-
translational modifications. Multiple sites on the Nrf2 protein 
are phosphorylated by kinases, such as PERK, members of 
the MAPK family, PKCζ, and GSK3β, increasing the nuclear 
translocation and binding of the protein to ARE elements on the 
promoters of target genes (8–10).
The PI3K/Akt pathway modulates Nrf2 signaling (11) and, 
importantly, recent reports have demonstrated the modula-
tion of the PI3K/Akt pathway upon Leishmania amazonensis 
infection (12). The enzyme GSK3, a target of Akt1, phos-
phorylates the Nh6 domain of Nrf2 and facilitates the action 
of ubiquitin ligase, leading to proteasomal degradation. The 
inhibition of GSK3 by phosphorylation allows the nuclear 
translocation of Nrf2 (13).
Kelch-like ECH-associated protein 1 (Keap1) is a major 
inhibitor of Nrf2 that constitutively induces the ubiquitination 
of the Nh2 domain, directing Nrf2 to proteasomal degradation. 
Keap1 is uncoupled from Nrf2 because of post-translational 
modifications due to oxidative stress, releasing Nrf2 for nuclear 
translocation (14).
Autophagy may modulate Nrf2 activation via Keap1 degra-
dation (15). The components of the autophagy pathway are sen-
sors of oxidative stress (16), and the increase in the expression 
of p62 (Sqstm1), an Nrf2 target autophagy gene (17), favors 
the cellular capacity to process proteins destined for the auto-
phagosome, decreasing oxidative stress (18).
The phosphorylation of p62 allows its binding to several 
cargo proteins, including Keap1, leading to autophagy as well 
as the Nrf2 stability and activation (19). The activation of Nrf2 
through the p62/autophagy non-canonical pathway has also been 
demonstrated in macrophages treated with LPS, PolyI:C and 
peptidoglycan (PGN) upon the engagement of TLR4, TLR3, and 
TLR2, respectively (20).
Double-stranded RNA-dependent protein kinase [protein 
kinase R (PKR)] has in the Nh2-terminal domain two double-
stranded RNA-binding motifs, and its kinase catalytic domain is 
located in the carboxyl-terminal (21, 22). On binding dsRNA, PKR 
dimerizes and undergoes autophosphorylation at multiple sites 
(23). Expression of catalytically defective mutant PKR (K296R) 
in cells inhibited the autophosphorylation and subsequent the 
activation of its major substrate eIF2-α (24, 25). PKR-mediated 
signaling may promote autophagy through eIF2-α phosphoryla-
tion (26). In several viral infections, PKR plays an essential role 
in the autophagy trigger (27). In STAT3−/− cells, PKR is able to 
induce autophagy through LC3-I to LC3-II conversion and the 
formation of vacuole compartments (28). In cells treated with 
type I interferon (IFN-I), both LC3 activation and p62 expression 
are increased (29).
In this work, we unveil the mechanisms that regulate Nrf2 
gene expression in a PKR-dependent fashion. We describe for 
the first time the signaling pathway that coordinates Nrf2 acti-
vation during Leishmania infection. Finally, the induction of 
cytoprotective genes through the novel PKR/Nrf2 pathway may 
represent a prominent therapeutic mechanism for treatment and 
guide the development of novel targets in both infectious and 
inflammatory diseases.
MaTerials anD MeThODs
reagents
Chloroquine diphosphate salt, dl-sulforaphane (SFN), phorbol- 
12 myristate-13 acetate (PMA), N-acetyl-l-cysteine (NAC), 
Wortmannin, and LY294002 hydrochloride were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). AKTi (AKT inhibitor VIII, 
Akt1/2) was purchased from Santa Cruz Biotechnology (Dallas, 
TX, USA). Poly (cytidylic-inosic) acid potassium salt (PolyI:C) 
and the PKR inhibitor CAS 608512-97-6 were purchase from 
Calbiochem-Millipore (Darmstadt, Germany). Human recom-
binant interferon-alpha 2b was obtained from Blausiegel (Cotia, 
SP, Brazil).
cell lines and culture
The mouse macrophage leukemia cell line RAW 264.7 (TIB-71; 
American Type Culture Collection (ATCC), Manassas, VA, 
USA), the human monocytic leukemia cell line THP-1 (ATCC:-
TIB202TM) and the human embryonic kidney cell line HEK-293T 
(ATCC:CRL-11268) were maintained in DMEM medium with 
high glucose (Vitrocell Embriolife, Campinas, SP, Brazil) sup-
plemented with 10% heat-inactivated fetal bovine serum (Sigma-
Aldrich, St. Louis, MO, USA). THP-1 cells were differentiated 
to macrophages with 40 ng/mL of PMA for 3 days. Afterward, 
the cells were washed three times with PBS and incubated 
with fresh medium for an additional 3  days. RAW 264.7 cells 
expressing either empty vector (RAW-Bla cells) or a dominant-
negative PKR K296R (RAW-DN-PKR cells) were donated by 
Dr. Aristóbolo Silva, Federal University of Minas Gerais, Brazil.
Peritoneal Macrophages
Ten-week-old male 129/SvEv PKR−/− (PKR-ko) and their respec-
tive wild-type littermates (WT) were used for experiments. Briefly, 
4 days before peritoneal lavage, 2 mL of 3% thioglycolate were 
intra-peritoneally injected in each mouse. Thioglycolate-elicited 
peritoneal macrophages from wild-type or PKR-knockout 129Sv/
Ev were obtained by injecting 8 mL of serum-free DMEM into 
the peritoneal cavity. After 1  h, the cells were washed once in 
PBS and then plated in in DMEM medium supplemented with 
10% FBS on glass coverslips at 2 × 105/well in 6-well or 24-well 
polystyrene plates for subsequent Leishmania infection assays.
cell Treatment
To induce the activation of Nrf2, 10 mM SFN were used as posi-
tive controls. For the inhibition of PKR activity, we pretreated the 
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cells for 1 h with 300 nM of the PKR inhibitor (PKRi). To induce 
PKR activation, poly(inosinic-cytidylic-) acid potassium salt 
(PolyI:C) at a final concentration of 25 µg/mL or recombinant 
IFNα-2b at 1,000 U/mL were used. PI3K/Akt inhibition was 
accomplished by cell treatment with 10 µM LY294002, 10 mM 
Wortmannin or 5  mM AKTI (AKT inhibitor VIII Akt1/2). 
To inhibit autophagy, we used 40 µM chloroquine. N-acetylcysteine 
(NAC) was used at a concentration of 10 mM.
Parasites, culture conditions, and 
infection
Leishmania (Leishmania) amazonensis (WHOM/BR/75/Josefa) 
and Leishmania (Viannia) braziliensis (BA788) were used in this 
study. The L. (L.) amazonensis strains obtained from biopsies 
of patients with diffuse cutaneous leishmaniasis (DCL) (Ba276, 
Ba336, and Ba760) or localized cutaneous leishmaniasis (Ba69, 
Ba73, and Ba125) were also used in vitro assays. The promas-
tigote forms were grown at 26°C in Schneider’s Insect Medium 
(Sigma-Aldrich) with 10% fetal bovine serum, and metacyclic 
promastigotes were collected from stationary cultures and used 
for cell infections. Macrophages were infected with Leishmania 
promastigotes at a parasite:cell ratio of 10:1 at 37°C. Infected 
macrophages were counted in a Neubauer Chamber by light 
microscopy to assess the infection index, which was calculated 
by multiplying the percentage of infected macrophages by 
the average number of parasites per macrophage in Giemsa-
stained slides.
immunoblotting
THP-1 cells (1  ×  106 cells) were washed twice with ice-cold 
PBS and then lysed in 100 µL of lysis buffer (50 mM Tris-HCl, 
pH 7.5, 5  mM EDTA, 10  mM EGTA, 50  mM NaF, 20  mM 
β-glycerophosphate, 250 mM NaCl, 0.1% Triton X-100, 1 µg/mL 
BSA, and a 1:100 dilution of protease inhibitor cocktail, Sigma-
Aldrich, St. Louis, MO, USA) for total protein extraction. For 
nuclear protein extraction, after infection and/or treatment, 
the cells were washed twice with 1x PBS and then lysed with 
100 µL of buffer A (HEPES 10 mM pH 7.9. 10 mM KCl, 0.1 mM 
EDTA, 0.1 mM EGTA, NP-40 0,25% (v/v); cocktail of protease 
inhibitors) for 10 min on ice. The lysed cells were centrifuged at 
14,000 g for 1 min at 4°C, and the pellet was resuspended in 60 µL 
of buffer C (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 
1 mM EGTA, 20% glycerol, protease inhibitor cocktail) and incu-
bated on ice for 20 min. The lysate was centrifuged at 14,000 g 
for 5 min, and the supernatant containing nuclear proteins was 
collected in a new tube. The protein extracts were subjected to 
electrophoresis on 10% SDS-polyacrylamide gels and trans-
ferred to nitrocellulose membranes (Amersham Biosciences, 
Piscataway, NJ, USA). After blocking with 5% non-fat dry milk 
in TBS with 0.1% Tween-20 (TBS-T), the blots were incubated 
over-night with antibodies against PKR (12297), Nrf2 (12721), 
GSK3 (9369), Sqstm1/p62 (5114), LC3B (2775), phospho-
GSK3β-Ser9 (9336), phospho-Akt-Ser473 (9271), phospho- 
eIF2α-Ser51 (9721), α-Tubulin (2144), β-Tubulin (2146), and 
Lamin A/C (2032) from Cell Signaling Technology; phospho-
PKR Th451 (07-886) from Millipore; keap1 (150654) from 
Abcam; and β-actin (47778), Sod1 (8637), followed by anti-rabbit 
(2004) or anti-mouse (2005) horseradish peroxidase-conjugated 
IgG (1:4,000) from Santa Cruz Biotechnology. The membranes 
were then submitted to three washes with 0.1% TBS-T after 
each incubation, and the proteins were detected using the ECL 
chemiluminescent detection system (Amersham Biosciences).
immunohistochemistry
To validate the differential expression of Nrf2 (C20—Santa Cruz 
Biotechnology) and keap1 (150654—Abcam) in DCL and LCL 
samples, immunohistochemistry was performed on formalin-
fixed, paraffin-embedded (FFPE) sections. Briefly, after deparaffi-
nization, rehydration and target retrieval (DAKO Corporation, 
Hamburg, Germany), slides from five DCL and five LCL cases 
were incubated with serum-free protein block reagent and 
then incubated overnight with Nrf2 or Keap1 (4and 10 mg/mL, 
respectively, both from Abcam, Cambridge, United Kingdom) or 
anti-rabbit isotype control antibodies. After the sequential applica-
tion of a peroxidase-blocking reagent, DAKO EnVision + System-
HRP (DAKO Corporation, Hamburg, Germany), digital images 
of the tissue sections were captured using a Nikon E600 light 
microscope and a Q-color 1 Olympus digital camera. Sec tions of 
prostate and lung adenocarcinoma were used as positive controls. 
Quantification of the stained areas was performed using Image Pro 
Plus software (Media Cybernetics).
luciferase assays
To investigate the promoter activity, RAW-264.7 cells (1 × 105 
cells per well) was plated in 48-well polystyrene plates and trans-
fected with 1 µg of reporter plasmids using LIPOFECTAMINE 
2000 reagent (Invitrogen, Carlsbad, CA, USA). THP-1 cells 
(2 ×  106) were transfected with 0.5  µg of luciferase reporter 
plasmids using Nucleofector™ Technology (Lonza, Basel, 
Switzerland) according to the manufacturer’s instructions. The 
following plasmids were employed in the assays: Sod1-basal, 
Sod1-ΔARE, Sod1-WT, 3xARE, and Nrf2-WT. For normaliza-
tion of the luciferase readout, the plasmid pRL-CMV (Promega) 
was used. After infection and treatment, the cells were washed 
with PBS, lysed according to the Dual Luciferase System proto-
col (Promega), and analyzed using the GloMax®-Multi detection 
system (Promega Corp., Madison, WI, USA).
chromatin immunoprecipitation  
assay (chiP)
Chromatin immunoprecipitation assay analysis was carried out 
according to the Simple ChIP Enzymatic Chromatin IP kit protocol 
(Cell Signaling). RAW 264.7 (WT-PKR and DN-PKR) cells or the 
human monocytic leukemia cell line THP-1 (ATCC:TIB202TM) 
were plated to confluence in 15  cm dishes. After infection, 
the cells were fixed with 1% formaldehyde for 10 min at room 
temperature, followed by the addition of glycine to a final con-
centration of 125 mM for 5 min at room temperature prior to cell 
lysis. One unit of micrococcal nuclease was added to the sample 
and incubated for 20 min at 37°C to digest DNA to the length of 
approximately 150–800 base-pairs. The chromatin was immuno-
precipitated with 5 µg/mL anti-Nrf2 antibody (D1Z9C-XP—Cell 
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Signaling Technology, Danvers, MA, USA) at 4°C under rotation 
for 16 h. The DNA isolated from the immunoprecipitated mate-
rial was amplified by real-time PCR using SybrGreen, and the 
DNA sequences of the primers used were Sod1-ARE.chip-F: 
5′-AAGTCCGGGTCCCAGCTCAGAG-3′ and Sod1-ARE.chip-
R: 5′-TTGGTGCAAGCACACCGGGAG-3′; p62-ARE.chip-F: 
5′-CCCCACAGTTCCCCATTGGC-3′ and p62-ARE.chip-R: 
5′-GACAGTGGGGACGCAAAGGC-3′; and Nrf2-ARE L2chip- 
F: 5′-AAGTCCGGGTCCCAGCTCAGAG-3′ and Nrf2-AREL2 
chip-R: 5′-TTGGTGCAAGCACACCGGGAG-3′. As a control, 
1/50 of the digested input chromatin was similarly processed 
and analyzed in the absence of immunoprecipitation. To calculate 
the input percentage of the samples, the input was adjusted to 
100% (average Ct of input − Log2 of 50), followed by the appli-
cation of the 100 × 2(adjusted input − average Ct(IP)) formula.
cloning and generation of luciferase 
reporter Plasmids
Total DNA was extracted from THP-1 cells using a Wizard® 
Genomic DNA Purification kit (Promega) and measured 
using a BioPhotometer (Eppendorf). One PCR was carried 
out with primers spanning different regions of the Sod1 and 
Nrf2 promoters, yielding different fragment sizes, in the fol-
lowing conditions: 20  ng of genomic DNA and 35 cycles of 
95°C for 1 min, 58°C for 1 min, and 72°C for 1 min. The DNA 
sequences of the primers used were Sod1.wt-F: 5′- GTCTCGA 
GCTGTAGGGTTGTGGCCTTGCCAAA-3′, Sod1.ΔARE-F: 
5′-GTCTCGAGGCCAATTTCGCGTACTGCAACCG-3′, Sod1.
basal-F: 5′-GTCTCGAGCTCGCGACCCGAGGCTG-3′ and 
Sod1-R: 5′-GTAGATCTCAGGAGACTACGACGCAAACCAG 
C-3′; and Nrf2-F: 5’ AAGTCCGGGTCCCAGCTCAGAG 3′ and 
Nrf2-R: 5′-TGGGGGCGGAACAAGGACCTAG-3′. A 1.8% aga-
rose gel was run for 50 min at 100 V, and the amplicons were extra cted 
from the gel and purified with the Zymoclean Gel DNA Recovery 
kit ™ (Zymo Research). The amplicons were ligated into a pJet- 
Blunt plasmid (Fermentas) with T4 ligase (Promega) for the 
first selection of positive colonies. After confirming positivity 
through PCR and a digestion assay, a colony was selected and 
grown, and a new plasmid extraction was performed. Digestion 
of the pJet-Blunt vector containing subcloned amplicons was 
performed with the Bgl-II enzyme (Promega), and the products 
were subjected to electrophoresis on a 2% agarose gel to extract 
the gel fragments. The pGL2-basic plasmid was also digested with 
the Bgl-II enzyme for the subsequent binding of the amplicons 
with T4 ligase enzyme (Promega). The cloned fragments and 
final vectors were then transformed into DH5α bacteria, and 
colonies were selected for further confirmation by sequencing. 
To obtain a luciferase-expressing pGL2-basic plasmid containing 
three copies of the sequence regulatory region ARE (3xARE), 
two oligos (5′-ATGCCGCTCGAGAATGACATTTCTAGAATG 
AC AT T T C TAG A AT G AC AT T T C TAG AG AT C T C G G 
CCG-3′ and 3′-TACGGCGAGCTCTTACTGTAAAGATCTT 
ACTGTAAAGATCT TACTGTAAAGATCTCTAGAGC 
CGGC-5′) were designed and annealed to serve as templates 
for a PCR under the following conditions: 20 ng of DNA oligo 
and 35 cycles of 95°C for 1 min, 52°C for 1 min, and 72°C for 
1 min with the primers 3xARE-F: 5′-ATGCCGCTCGAGAATG 
3′, and 3xARE-R: 5′-CGGCCGAGATCTCTAGA 3′. The binding 
reactions and digestion with the Bgl-II enzyme followed the same 
protocol as described above.
lentiviral Production and ThP-1 
Transduction
HEK-293T  cells were used for shNrf2 lentiviral production. 
Initially, we co-transfected the cells with two packaging plasmids 
(pΔ8.9 and pVSVG) containing accessory proteins for the gen-
eration of the virus and capsid, respectively, along with the plas-
mid pLKO.1-shMission-Nrf2 (Sigma-Aldrich). For HEK-293T 
transfection, 60 µL of FuGENE HD reagent (Promega) was used 
in a 100 mm dish containing approximately 4 × 106 cells, along 
with 10 µg of target plasmid, 6 µg of pVSVG and 4 µg of pΔ8.9. 
After 24  h of transfection, the culture medium was changed 
and, over the next 2  days, the supernatants were collected at 
10  mL/day. The 20  mL of supernatant was ultracentrifuged at 
16,000 rpm for 90 min at 4°C, and the pellet was resuspended in 
1 mL of DMEM without serum. Viral transduction in THP-1 cells 
was accomplished in 2 × 106 cells incubated with 1 mL of virus 
preparation for 48 h.
Fluorimetric assays
The production of reactive oxygen species (ROS), nitric oxide 
(NO), and peroxynitrite (OONO) was performed by fluorim-
etry. For this, 105 cells were seeded in black 96-well plates and 
maintained for 24  h in DMEM containing 10% fetal bovine 
serum. The day after, the cells were washed three times with PBS, 
and HBSS medium without serum was added and incubated for 
1 h at 37°C and 5% CO2. The cells were incubated with different 
fluorescent probes for 1  h. Then, the cells were washed with 
PBS and treated with medium or infected with L. amazonensis. 
Fluorescence counting was monitored after incubation at 1-h 
intervals for up to 6 h (GloMax™). The production of ROS was 
detected using the probe CM-H2DCFDA (5  mM, Molecular 
Probes), with excitation at 495  nm and emission at 525  nm. 
For NO production, the DAF-FM probe (5  mM, Molecular 
Probes) was used, with excitation at 495 nm and emission at 
515 nm. For the production of OONO-, the probe HPF (5 mM, 
molecular probes) was used, with excitation at 490  nm and 
emission at 515 nm.
Patient characteristics
Diffuse cutaneous leishmaniasis patients (n = 4) were recruited at 
our reference clinic in São Luiz, Maranhão, Brazil. DCL patients 
exhibited chronic progression of the disease with several remis-
sions, multiple nodular and highly parasitized lesions through-
out the skin, and a negative DTH response. LCL patients (n = 5), 
recruited at our reference clinic in Jiquiriçá, Bahia, Brazil, had a 
single or a few ulcerated lesions present for up to 2 months and 
a positive DTH response (30). The clinical and epidemiological 
data from patients with DCL and those with LCL are summa-
rized in Table S3 in Supplementary Material. Skin biopsies were 
preserved as paraffin-embedded specimens.
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Patient recruitment and Diagnosis for 
Transcriptomic analysis
This study was approved by the Ethics Committee of the Gonçalo 
Moniz Research Center (FioCruz-Bahia). Informed consent was 
obtained from all patients and healthy controls. CL patients 
were diagnosed according to characteristic lesion morphology, 
positive skin test, seropositivity toward Leishmania antigen and/
or the presence of parasites in the lesion. LCL patients infected 
with Leishmania braziliensis (n = 18, 10 male, 29.6 ± 2.3 years) 
were recruited at diagnosis (before treatment) in two outpatient 
clinics (Jequié and Jiquiriçá-BA, NE Brazil) covering the same 
rural area.
ethics statement
Written informed consent was obtained from all participants or 
legal guardians, and all of the data analyzed were anonymized. 
The project was approved by the Institutional Review Board 
of Centro de Pesquisas Gonçalo Moniz, FIOCRUZ–BA (license 
number 136/2007) and complies with the guidelines of the Dec-
laration of Helsinki.
Microarray analysis
PBMCs from LCL patients and healthy controls were processed 
in parallel and immediately frozen in Trizol to preserve RNA 
integrity. Following Trizol extraction, total RNA was further puri-
fied using an RNeasy kit according to the manufacturer’s protocol 
(QIAGEN, Venlo, Netherlands). Affymetrix Whole Genome 
microarray analysis was performed by the VIB MicroArray 
Facility (Leuven, Belgium) using a GeneChip® Human Gene 1.0 ST 
Array with the WT PLUS reagent kit (Affymetrix, Santa Clara, 
CA, USA) according to the manufacturer’s specifications. Data 
preprocessing (RMA) was performed using the Bioconductor 
xps package. Microarray data were deposited in GEO (accession 
number: GEO Submission (GSE80008) (NCBI tracking system 
#17832057)).
ncounter Digital Transcriptomics
RNA extraction from skin biopsies was performed as above. 
Digital quantification of selected genes (NRF2, PKR, SOD1, 
SOD2, KEAP1, HMOX1) was performed by nCounter (Nano-
string). Two-step normalization using internal positive and 
nega tive control RNAs, as well as PTPRC (CD45) normalization 
to correct for differences in tissue leukocyte infiltration, was 
performed as previously described (31).
enrichment analysis
The ingenuity pathway analysis (IPA) program was used to per-
form the initial pathway/function level analysis on genes deter-
mined to be differentially expressed in the microarray analysis 
(IPA version 9.0, Build 116623, Content version 3211, Ingenuity 
Systems, Red Wood City, CA, USA). Uncorrected p-values and 
absolute fold-changes were used with cut-offs of p < 0.05. Based 
on a scientific literature database, the genes were sorted into gene 
networks and canonical pathways, and significantly overrepre-
sented pathways were identified. Further enrichment analysis 
was performed, including Gene Ontology (GO) term enrichment 
using the WEB-based GEne SeT AnaLysis Toolkit (WebGestalt), 
KEGG pathway enrichment using the pathway database from the 
Kyoto Encyclopedia of Genes, and Genomes and transcription 
factor target enrichment using data from the Broad Institute 
Molecular Signatures Database (MSigDB). Genesets from the 
GO, KEGG pathways, WikiPathways, and Pathway Commons 
databases, as well as transcription factors, were considered over-
represented if their corrected p-value was smaller than 0.05.
statistical analysis
The data were analyzed by one-way ANOVA for independent 
samples or Mann–Whitney (two-sided t-test) using Prism 5 soft-
ware. The data represent the mean ± SD of the mean. The data 
are expressed as the average of three independent determina tions, 
and significant differences were indicated by *p < 0.05.
resUlTs
Leishmania induces nrf2 via PKr
The oxidative stress response plays a determinant role in the 
control of intracellular pathogens such as Leishmania (32). 
 L. amazonensis dampens some macrophage functions, including 
the induction of oxidative stress (33, 34). Importantly, Nrf2 acti-
vation may promote infection tolerance, thus favoring pathogen 
survival. We sought to investigate whether L. amazonensis would 
induce Nrf2 via PKR. Figure 1A and Figure S1A in Supplementary 
Material shows that Nrf2 translocated to the nuclei of mac-
rophages during the initial phase of interaction with the parasite. 
Importantly, Nrf2 translocation was not observed in infected 
pkr-ko and DN-PKR macrophages, respectively. Nrf2 levels were 
augmented in 6 h of infection and were induced by PKR signaling 
(Figure 1B; Figure S1B in Supplementary Material). The main 
target of PKR, eIf2α, is also not activated by phosphorylation in 
PKR-deficient cells (Figures S1C,D in Supplementary Material). 
PKR activation by inducers, such as PolyI:C or IFN-I added to 
macrophages also induced Nrf2 translocation and expression 
(Figure 1C). Next, we investigated the binding of Nrf2 to cognate 
Nrf2 promoter (Figure 1D). Our data show that Nrf2 only occu-
pied the ARE sequences in infected wild-type macrophages by 
ChIP. To address whether ARE genes are activated in Leishmania 
infection, we constructed two luciferase reporter plasmids. The 
3xARE construct contains the canonical ARE promoter response 
element, while the other construct contains the Nrf2 promoter 
(also spanning an ARE-like element). Figure  1E shows that 
the 3xARE regulatory sequence drove luciferase expression in 
infected wild-type macrophages, while luciferase expression was 
abrogated in DN-PKR cells. Importantly, the Nrf2 promoter was 
also induced in infected wild-type macrophages. In summary, 
our results show that L. amazonensis induces Nrf2 in a PKR-
dependent manner.
nrf2 and PKr signaling control sOD1 
gene expression
Recent reports have demonstrated that L. amazonensis activates 
the classical antiviral response mediated by PKR, leading to Sod1 
FigUre 1 | Leishmania amazonensis induced nuclear factor erythroid 2-related factor 2 (Nrf2) expression and nuclear translocation in a protein kinase R (PKR)-
dependent manner. Peritoneal macrophages from wild-type or PKR-ko 129/sv mice were infected with stationary promastigotes forms of L. amazonensis for 2 h  
(a) or 6 h (B). Western-blot was carried out for nuclear or total protein extract, respectively, and then assay was performed using Nrf2 antibody. (c) THP-1 cells 
were infected with Leishmania amazonensis or treated with IFN-α or PolyI:C for 2 h for nuclear extract or 6 h for total protein extract, before western-blot analysis 
with Nrf2 antibody. (D) RAW-WT-PKR and RAW-DN-PKR cells were infected with stationary promastigotes forms of L. amazonensis for 4 h and then submitted to 
chromatin immunoprecipitation assay (ChIP) using Nrf2 ChIP-antibody. (e) RAW 264.7 cells were transiently transfected with p3xARE- or pNrf2-promoter-luciferase 
reporter plasmids constructs and infected with L. amazonensis 24 h post-transfection. Whole-cell lysates were analyzed for luciferase activity 24 h later. Results are 
representative of three independent experiments. *p < 0.05.
6
Vivarini et al. PKR–Nrf2 Crosstalk in Leishmania Infection
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1127
expression, favoring parasite growth in infected macrophages 
(35, 36). To address the role of Nrf2 on Sod1 expression in 
infected macrophages, we cloned the Sod1 promoter and 
deleted the regulatory regions in the Luciferase vector (pGL2) 
(Figure  2A). The Sod1 promoter was induced in wild-type 
infected macrophages, while the deletion of the ARE sequence 
disrupted Luc expression. Accordingly, Sod1 expression, which 
is controlled by Nrf2, was only increased in wild-type infected 
macrophages (Figure  2B). Our data show that ARE element 
on Sod1 promoter was occupied by Nrf2 only in infected wild-
type macrophages by ChIP (Figure 2C). We aimed to test the 
hypothesis that Sod1 dependence of Nrf2 activity, we developed 
a macrophage shNrf2 knockdown cell line. In only wild-type 
infected macrophages, the parasites induce Sod1 expression 
(Figure  2D). The quantification of infection index show a 
decrease on proliferation of Leishmania in Nrf2 knockdown cells 
FigUre 2 | Sod1 regulation through nuclear factor erythroid 2-related factor 2 (Nrf2) and protein kinase R (PKR) signaling. (a) RAW 264.7 WT or DN-PKR cells were 
transiently transfected with Sod1-Luc plasmids and infected with stationary promastigotes of Leishmania amazonensis for additional 24 h before luciferase activity 
assay. (B) The same cells were also infected with stationary promastigotes of L. amazonensis for 18 h before total protein extract for western-blot analyzes with  
Sod1 and α-tubulin antibodies. (c) RAW 264.7 cells were infected with stationary promastigotes forms of L. amazonensis for 4 h and then submitted to chromatin 
immunoprecipitation assay (ChIP) using Nrf2 ChIP-antibody. shNrf2 or shControl THP-1 cells were infected with stationary promastigotes of L. amazonensis,  
(D) Sod1 protein expression was analyzed, and (e) infection index was evaluated. Results are representative of three independent experiments. *p < 0.05.
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(Figure 2E). These data support the link between Sod1 and two 
major signaling pathways represent by Nrf2 and PKR.
akt1 controls nrf2 induction in infected 
Macrophages
Nrf2 activation is controlled at different levels, including indirect 
phosphorylation by Akt1 (11). Because L. amazonensis promotes 
Akt1 activation (12), we aimed to investigate its role in Nrf2 
induction. Initially, we examined whether the induction of Akt1 
by L. amazonensis relied on PKR expression. Figure 3A shows 
that GSK3 phosphorylation due to Akt1 depended on PKR. The 
phosphorylation of Akt depends on PKR during Leishmania infec-
tion (Figures S3A,B in Supplementary Material). Of note, Nrf2 
induction required Akt signaling, as shown in infected shAkt1 
macrophages (Figures  3B,C). In macrophages treated with 
pharmacological inhibitors of Akt1/2 and PI3K (Figures 3D,E), 
we also observed the same pattern of Nrf2 repression in nucleus 
translocation and protein expression. As predicted, ARE element, 
Nrf2 Luciferase and Nrf2 promoter occupancy in ChIP assay 
were induced by L. amazonensis infection in an Akt1-dependent 
manner (Figures 3F,G). Likewise, Sod1 expression followed the 
same PI3K/Akt1 dependence pattern. ChIP assays corroborated 
these findings, where the occupancy of ARE in the Sod1 pro-
moter by Nrf2 depended on Akt1 (Figure 3H).
nrf2 Knockdown Promotes Oxidative 
stress and impairs Parasite survival  
in Macrophages
We aimed to test the hypothesis that Nrf2 knockdown would 
favor oxidative stress, leading to the reduction of the parasite 
load in macrophages. We measured the production of OONO, 
NO, and ROS as components of the oxidative stress pathway 
in Nrf2-knockdown infected macrophages (Figure  4A). As 
expected, the production of ROS and the formation of OONO 
and NO were enhanced in infected Nrf2-knockdown mac-
rophages. Figure 4B shows that PKR or Akt1 inhibition leads 
to a similar oxidative stress profile upon infection. Silencing of 
Nrf2 decreased the infection index, whereas the parasite load 
was rescued when infected Nrf2-knockdown macrophages 
were treated with the antioxidant NAC compound (Figure 4C). 
FigUre 3 | Protein kinase R (PKR)-dependent PIK3/Akt signaling activation controls positively the nuclear factor erythroid 2-related factor 2 (Nrf2) functions in 
Leishmania-infected macrophages. (a) Peritoneal macrophages from wild-type or PKR-ko 129/sv mice were infected with stationary promastigotes forms of 
Leishmania amazonensis at indicated times. Western-blot was carried out for total protein extract with anti-phospho-GSK3 and anti-GSK3. THP-1 cells stably 
knocked-down for Akt1 expression (B,c) and treated with PI3K/Akt inhibitors (LY294002, Wortmannin and Akt-inhibitor-VIII) (D,e) were infected with stationary 
promastigotes forms of Leishmania amazonensis at indicate times. Nuclear and total protein extracts were analyzed using Nrf2 antibody. (F) THP-1 cells were 
transiently transfected with p3xARE- or pNrf2-promoter Luciferase reporter plasmids. Twenty-four hours post-transfection, cells were differentiated into 
macrophages with phorbol-12 myristate-13 acetate (PMA) treatment for 6 days. The cells were infected with stationary promastigotes forms of L. amazonensis  
and/or treated with PI3K/Akt inhibitors for additional 24 h. Whole-cell lysates were analyzed for luciferase activity 24 h later. THP-1 cells were infected with stationary 
promastigotes forms of L. amazonensis and/or treated with Akt-inhibitor-VIII for 4 h and then submitted for chromatin immunoprecipitation assay (ChIP) using Nrf2 
ChIP-antibody and primers for Nrf2 (g) and Sod1 (i) promoters. (h) Western-blot for total protein extract analyses with Sod1 antibody was performed at same 
conditions of infection and treatment. Results are representative of three independent experiments. *p < 0.05.
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Notably, the Nrf2 inducer sulforaphane augmented the infec-
tion index.
Leishmania Down-regulates the nrf2 
negative regulator Keap1 and induces 
autophagy
Nuclear factor erythroid 2-related factor 2 is sequestered in 
the cytosol by a homodimer of Keap1, which limits its nuclear 
translocation. Nrf2 associated with Keap1 is directed to pro-
teasomal degradation by Cul3-mediated poly-ubiquitination 
(37). However, Keap1 is degraded through p62-mediated 
autophagy, releasing Nrf2 into the nucleus (38). Given that 
Leishmania induces autophagy in infected macrophages (39), 
we sought to investigate the levels of Keap1 in Leishmania infec-
tion. Figure 5A shows the prompt decrease in Keap1 levels in 
infected macrophages and demonstrates that PKR inactivation 
prevented Keap1 degradation. Moreover, Keap1 reduction was 
prevented by chloroquine, an autophagy inhibitor (Figure 5B). 
Given that Nrf2 released via Keap1 degradation promotes the 
antioxidant response, we addressed whether the inhibition 
of autophagy would increase the oxidative stress of infected 
macrophages. As observed in Figure  5C, the levels of ROS, 
OONO, and NO increased in infected cells treated with chlo-
roquine. We also confirmed that L. amazonensis triggers LC3-I 
conversion to LC3-II, a marker of autophagy (Figure 5D). Given 
that the formation of the LC3-p62-Keap1 ternary complex on 
the autophagosome membrane directs Keap1 to degradation 
FigUre 4 | Continued
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FigUre 4 | The reactive oxygen species (ROS) were enhanced upon Leishmania amazonensis infection in nuclear factor erythroid 2-related factor 2 (NRF2)/protein 
kinase R (PKR)/Akt-deficient macrophages. (a) shNrf2 or shControl and (B) wild-type THP-1 cells treated with PKR-inhibitor or Akt-inhibitor-VIII were infected with 
stationary promastigotes forms of L. amazonensis at indicated times together with probes for quantifying peroxynitrite (OONO), nitric oxide (NO), and ROS, and then 
analyzed as described in material and methods. (c) THP-1 transiently knocked-down for Nrf2 expression or shControl cells were infected with stationary 
promastigotes forms of L. amazonensis for 24 h and treated for additional 24 h with sulforaphane (SFN) or NAC (N-acetylcysteine) before the analysis of infection 
index. The asterisk means the statistic significant differences between the groups. Results are representative of three independent experiments. *p < 0.05.
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(40), we investigated the induction of p62 in the infection. We 
show that p62 was induced in infected macrophages, and this 
effect relied on PKR and Akt1 (Figure 5E and Figures S5A in 
Supplementary Material, respectively). Moreover, the ablation 
of Nrf2 expression pre vented p62 induction due to infection 
(Figure  5F). Given that our data indicate that PKR and Akt 
control the induction of Nrf2, we tested the occupancy of the 
p62 promoter by Nrf2 in the context of infection. Our data show 
that Leishmania promoted Nrf2 occupancy, and the inhibition of 
either PKR or Akt signaling prevented this effect (Figure 5G and 
Figure S5B in Supplementary Material, respectively).
nrf2 Protein levels are elevated in human 
cl, and L. braziliensis also induces nrf2 
In Vitro
We aimed to address whether other L. amazonensis strains 
isolated from patients with localized cutaneous lesions (LCL) 
or DCL would induce Nrf2 nuclear translocation and the 
activation of PKR. Figure 6A shows that all distinct strains of 
L. amazonensis activated PKR and Nrf2. Given that most of the 
cases of human CL in Brazil are caused by L. braziliensis, we 
decided to address whether this species would induce PKR and 
Nrf2. Figure  6B shows that L. braziliensis activated PKR and 
Nrf2. Nrf2 activation depended on PKR function (Figure 6C). 
Moreover, the expression of the Nrf2 target genes p62 and 
Sod1 was reduced in Nrf2-silenced L. braziliensis-infected 
macrophages (Figure  6E), and the growth of amastigotes was 
impaired in Nrf2-knockdown macrophages (Figure  6D). 
These results prompted us to investigate the levels of Nrf2 and 
the negative regulator Keap1 in clinical samples from LCL or 
DCL patients. Figure 6F shows the marked expression of Nrf2 
in DCL samples compared to LCL tissues. Accordingly, Keap1 
expression was enriched in LCL samples. Altogether, the data 
show that Nrf2 induction is triggered by distinct species and 
strains of L. amazonensis, and high levels of Nrf2 are found 
in patients with DCL, a severe clinical condition that presents 
with a high number of parasites and poor prognosis (41).
Transcriptomic analysis reveals a  
Pivotal role of nrf2 signaling in cl  
Patient samples
Next, we tested for transcription factor enrichment among 
the 413 genes composing the systemic LCL disease signature. 
Only five transcription factor motifs were significantly enriched 
among the promoters of the 413 genes of the LCL disease 
signature. After the E4F1 motif, the Nrf2 binding site was the 
second-most significantly represented, being present in 15 of 
the 413 genes composing the LCL disease signature (Table 1). 
Among those, p62 (Sqstm1), in bold, was confirmed, in agree-
ment with our in vitro data. We herein present the first disease 
signature of LCL using a systems biology analysis of the PBMC 
transcriptome of LCL patients (n  =  18) vs. healthy controls 
(n = 12). Using Affymetrix microarrays (HuGene 1.0), we found 
that Nrf2 was significantly overexpressed in patient PBMCs vs. 
controls (1.8-fold, uncorrected p = 0.0002, p = 0.033 using the 
Benjamini–Hochberg correction for genome-wide testing). 
The top 50 upregulated genes in patients vs. controls are shown 
in Table S1 in Supplementary Material. Next, we used IPA to 
determine which biological pathways and molecular networks 
were enriched among the LCL disease signature. As shown in 
Table S2 in Supplementary Material, three antioxidant pathways, 
i.e., the thioredoxin pathway, the antioxidant action of Vitamin 
C and the Nrf2 pathway, were significantly enriched in the LCL 
disease signature.
FigUre 5 | The nuclear factor erythroid 2-related factor 2 (Nrf2)-inhibitor Kelch-like ECH-associated protein 1 (Keap1) is modulated negatively through protein 
kinase R (PKR) signaling and p62 autophagy-dependent manner in Leishmania infection. (a) RAW-WT-PKR and RAW-DN-PKR cells were infected with stationary 
promastigotes forms of Leishmania amazonensis for 2 or 4 h and then western-blot assay were performed with total protein extract using Keap1 antibody.  
(B) THP-1 cells were infected with stationary promastigotes forms of L. amazonensis at indicate times and/or treated with chloroquine and the total or nuclear 
protein extracts were analyzed using Keap1 and Nrf2 antibodies. (c) THP-1 cells treated with chloroquine were infected with stationary promastigotes forms of  
L. amazonensis at indicated times together with probes for quantifying OONO, NO, and ROS. (D) THP-1 cells were infected with stationary promastigotes forms  
of L. amazonensis and western-blot for LC3-I/II protein was performed. RAW-WT-PKR and RAW-DN-PKR cells (e), and shNrf2 or shControl THP-1 cells  
(F) were infected with stationary promastigotes forms of L. amazonensis and then the total protein extract was analyzed by western-blot assay with p62  
antibody. (g) RAW-WT-PKR and RAW-DN-PKR were infected with stationary promastigotes forms of L. amazonensis for 4 h and then submitted for ChIP  
assay using Nrf2 ChIP-antibody and primers for p62 promoter. Results are representative of three independent experiments. *p < 0.05.
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nrf2 Transcriptome-Wide correlations 
confirm the links between iFn-i/PKr, 
are, PiK3, and autophagy signaling 
Pathways In Situ
Then, we performed a transcriptome-wide correlation analysis 
to further investigate whether the molecular links we described 
at the protein level in vitro might be confirmed at the transcrip-
tional level ex vivo. The expression of a large number of genes 
was significantly correlated to Nrf2 transcript levels, even fol-
lowing stringent Benjamini–Hochberg correction for multiple 
testing. Among those, PKR, PIK3C, Sod1, and p62 (SQSTM1) 
transcripts were positively correlated, whereas Keap1 was 
negatively correlated, to Nrf2 transcript levels, with minor 
differences between LCL patients and controls (Figure  7A), 
thus confirming our protein data of Nrf2 regulation, both 
upstream or downstream. To validate these microarray results, 
we performed a targeted analysis of key genes in the Nrf2/PKR 
crosstalk using nCounter digital transcriptomic quantification 
in LCL (n = 6) as well as healthy skin biopsies (n = 4). As shown 
in Figure  7B, unsupervised hierarchical clustering of in  situ 
transcriptomes revealed two major clusters, which coincided 
with either LCL patients or normal donors (ND). Thus, LCL 
skin biopsies could be discriminated from healthy skin by 
FigUre 6 | Leishmania braziliensis and different strains of Leishmania amazonensis infections also modulated positively the protein kinase R (PKR)/nuclear factor 
erythroid 2-related factor 2 (Nrf2) axis pathway. (a) L. amazonensis strains from LCL or diffuse cutaneous leishmaniasis (DCL) patients were used to infect THP-1 
cells. Total or nuclear protein extracts were processed and then analyzed by western-blot with phospho-PKR and Nrf2 antibodies, respectively. (B) THP-1 cells were 
infected with stationary promastigotes forms of L. braziliensis at indicate times and then performed for western-blot with phospho-PKR and Nrf2 antibodies, and 
3xARE-promoter Luciferase assays. Peritoneal macrophages of wild-type or PKR-ko mice were infected with L. braziliensis and infection index assays were then 
analyzed. (c) RAW-WT-PKR and RAW-DN-PKR cells were infected with L. braziliensis and western-blot with anti-Nrf2 was then analyzed. (D) shNrf2 or shControl 
THP-1 cells were infected with stationary promastigotes forms of L. amazonensis for 24 h before treatment with NAC or polyI:C for additional 24 h. After this time, 
the cells were fixed and the infection index was evaluated. (e) THP-1 transiently knocked-down for Nrf2 expression or shControl cells were infected with stationary 
promastigotes forms of L. amazonensis for 4 or 6 h before total protein extract for western-blot analyzes with p62 and Sod1 antibodies. (F) Histological sections 
from biopsies obtained from lesions of patients with DCL (n = 4) or with LCL (n = 5) were submitted to immunohistochemical reaction with primary antibodies 
against Nrf2 or Keap1 as previously described. All sections were counterstained with hematoxylin. Digital images (400× magnification) were captured using a  
Nikon E600 microscope and an Olympus Q-Color 1 digital camera with the Image Pro Plus program. Bars represent 10 µm. Positive cell density was obtained. 
Graph represents the analysis of reactive positive cells for Nrf2 and Keap1 compared with isotype controls as percentage of positive stained area per total tissue 
area. Results are representative of three independent experiments. *p < 0.05.
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TaBle 1 | Gene promoters in LCL disease signature are enriched for nuclear 
factor erythroid 2-related factor 2 transcription factor binding sites.
index gene symbol gene name entrez 
gene
1 TXNRD1 Thioredoxin reductase 1 7296
2 TFAP4 Transcription factor AP-4 7023
3 sQsTM1 sequestosome 1 8878
4 RB1CC1 RB1-inducible coiled-coil 1 9821
5 CDH23 Cadherin-related 23 64072
6 SLC16A6 Solute carrier family 16, member 6 9120
7 KBTBD8 Kelch repeat and BTB (POZ) domain  
containing 8
84541
8 FBXO30 F-box protein 30 84085
9 ATP1B1 ATPase, Na+/K+ transporting, beta 1 
polypeptide
481
10 PRDM1 PR domain containing 1, with ZNF domain 639
11 MAST2 Microtubule-associated serine/ 
threonine kinase 2
23139
12 CLC Charcot–Leyden crystal protein 1178
13 SYTL1 Synaptotagmin-like 1 84958
14 SFXN5 Sideroflexin 5 94097
15 TMEM57 Transmembrane protein 57 55219
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differential expression of only six transcripts (Nrf2, PKR, Sod1, 
Sod2, Keap1, and Hmox1).
DiscUssiOn
The oxidative burst in infected cells is a key microbicide mecha-
nism exhibited by macrophages. However, Leishmania parasites 
present a repertoire of adaptive mechanisms to cope with the 
altered redox state of infected macrophages by expressing antioxi-
dant enzymes or interfering with macrophage signaling pathways 
(42). A growing number of reports indicate that PKR modulates 
infections caused by intracellular pathogens (43). Notably, 
increased levels of Sod1 are expressed in macrophages infected 
by L. amazonensis due to PKR activation (35). Given that the 
transcription factor Nrf2 is the main regulator of Sod1 expression 
(44) among other genes involved in the anti-oxidative response, 
we studied the regulation of Nrf2 in the context of Leishmania 
infection and tested the hypothesis that PKR is actually a positive 
regulator of the ARE via Nrf2.
Our results demonstrated that Nrf2 activation depended on 
PKR signaling. Simple treatment with PKR inducers such as 
IFN-α and PolyI:C increased the expression and nuclear translo-
cation of Nrf2, demonstrating that the mechanisms of Nrf2 acti-
vation through PKR pathway signaling are not exclusively due 
to Leishmania infection. Remarkably, PKR activation induces 
a significant increase in Nrf2 expression. PKR phosphorylates 
eIF2-α, which reduces protein synthesis while upregulating the 
expression of some genes such as ATF-4. The 5′untranslated 
region of Nrf2 mRNA presents an internal ribosomal entry site 
(IRES), allowing enhanced Nrf2 translation in eIF2-α-mediated 
protein translation (45, 46).
The control of Nrf2 activation requires different post-
translational modifications as well as its repression and 
subsequent degradation via the proteasome (8–11, 47). The 
non-canonical PI3K/Akt signaling pathway has been linked to 
the activation of Nrf2 in a number of models. GSK3-mediated 
inhibitory phosphorylation induces Nrf2 by inhibiting the 
phosphorylation signal and sequential ubiquitination in the 
Neh6-Nrf2 domain, allowing its stability and activity (13). In 
Leishmania infection, PI3K and Akt inhibition reduced the 
expression of Nrf2 and Sod1 (Figure 3). Our results led us to 
conclude that PI3K/Akt activation as a result of Leishmania 
infection is a positive Nrf2 regulator in host cells.
The rise of ROS seems to be a key regulator of infection by 
intracellular pathogens (48), and the co-evolution of host cells 
and parasites results in a shared pattern of subversion in the 
production of these radicals. For example, Trypanosoma cruzi 
infection in THP-1 cells requires a level of oxidative stress for 
successful parasitism, given that the overexpression of Nrf2 
reduces parasitism (49). Our data from in vitro Nrf2-knockdown 
macrophages revealed the spontaneous increase of oxidative 
stress, measured through the levels of ROS, NO, and OONO. 
The same change in phenotype occurred when PKR and Akt 
were inhibited, probably due to the reduction of Sod1 and other 
targets. However, the infection index increased when the cells 
were treated with SFN and NAC. Our data suggest that Nrf2 
activation induces Sod1, thus counteracting the oxidative boost 
in the cell milieu in infected macrophages.
Several reports (50) have highlighted the close relationship 
between oxidative stress and the autophagy process. The auto-
phagy pathway plays an important role in resistance to various 
infections, although it could be subverted, thus favoring some 
infections (51). It is conceivable that autophagy induced by 
L. amazonensis may be controlled by PKR, as revealed in other 
models, thus regulating Nrf2 levels. Accordingly, some stud-
ies have shown the importance of oxidative stress sensing in 
autophagy (15, 16) and have demonstrated that the degradation 
of Keap1 via autophagy allows cellular redox homeostasis in 
liver cells. Our data showed that infected macrophages display 
an increase in LC3-I to LC3-II conversion, thus corroborat-
ing the importance of autophagy through this marker during 
infection.
Kelch-like ECH-associated protein 1 is a negative regula-
tor of Nrf2, and in the context of infection by Leishmania, we 
demonstrated that Keap1 is regulated after 18 h of infection in a 
PKR-independent manner (data not included). However, Keap1 
stability is decreased in a PKR-dependent manner between 2 
and 4 h of infection. When autophagy was inhibited by chlo-
roquine, we noted a cytoplasmic accumulation of Nrf2 and 
sta bilization of Keap1 levels, which was accompanied by high 
levels of oxidative stress.
Several studies have shown the involvement of the p62 
(Sqstm1) protein as a central regulator between Keap1 and 
Nrf2. Oxidative stress decreases when cells overexpressing p62 
bind to this inhibitory protein, leading to autophagosome for-
mation (19, 20). Other studies have shown that Nrf2 positively 
regulates the expression of p62 (17). Importantly, TLR2 acti-
vation culminates in M2 polarization of macrophages (MOX 
FigUre 7 | Nuclear factor erythroid 2-related factor 2 (Nrf2) transcriptome-wide correlations confirm the links between IFN/protein kinase R (PKR), antioxidant 
response element (ARE), PIK3, and autophagy signaling pathways in situ. (a) Transcriptome-wide correlation analysis was applied to Nrf2 transcript levels in 
microarray data (Illumina) obtained from skin biopsies from LCL patients (n = 20, red) and healthy controls (n = 10, green). Spearman correlation coefficient and 
p-values are shown for individual transcripts, 95% confidence intervals are shown in gray for patients only. (B) Validation of increased PKR/Nrf2 signaling pathway 
members by digital mRNA quantification. Heat map and hierarchical cluster analysis (Eucledian distance) of selected genes quantified by nCounter digital 
transcriptomics (Nanostring) in skin biopsies from normal donors (ND, n = 4) and LCL patients (n = 6), normalized according to PTPRC (CD45) expression  
levels, to account for differences in tissue leukocyte infiltration.
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macrophages), which leads to NF-κB-p65 degradation through 
p62 and lysosomes, characterized by selective autophagy (52). 
M2 macrophages exhibit antioxidant properties, as judged by 
the expression of Cox2, IL1β, HO-1, VEGF, and Nrf2 (53). 
Considering the cascade of signals, our data support the 
notion that the PKR–PI3K/Akt↔Nrf2 axis regulates p62 gene 
expression in Leishmania infection and passively triggers the 
autophagy pathway that culminates in Keap1 degradation, 
activating Nrf2 and resulting in oxidative cellular homeostasis.
Patients with localized cutaneous lesion (LCL) exhibit 
predominant expression of iNOS, IL-1β, IL-6, MCP-1, TNF-α, 
and IFN-γ, while anergic diffuse cutaneous leishmaniasis (ADCL) 
lesions are characterized by the presence of IL-4, IL-5, IL-10, and 
MIP-1α and the low expression of iNOS (54, 55). Our in vitro 
data showed that L. braziliensis, the prominent causative agent 
of LCL, also induces Nrf2 in a PKR-dependent fashion. This 
observation underlines the importance of this signaling pathway 
in other Leishmania species besides L. amazonensis. However, 
the immunohistochemistry analysis of LCL vs. DCL lesions 
revealed a strong Nrf2 reaction in the latter group, while the 
Keap1 signal was predominant in the former clinical samples. 
These results indicate that Nrf2 activation may contribute to the 
poor oxidative response and, consequently, the high parasite 
burden in DCL patients.
The data obtained in this study confirm and extend our previ-
ous finding of an IFN-I/Sod1 axis, linked to increased parasite 
burden (56) and therapeutic failure in both localized cutaneous 
leishmaniasis and DCL (31). This study now reveals that this 
IFN-I/Sod1 link is critically mediated by Nrf2/ARE signaling. 
Our genome-wide study revealed Nrf2 as a master regulator 
of the in situ (skin biopsies) transcriptome (Figure 7), both in 
health and disease, which is in agreement with its central role 
in proteostasis and ancient molecular networks, conserved in 
evolution from Drosophila to man (57). There is a negative 
correlation with the Keap1 transcript skin biopsies, which was 
corroborated by our findings at the protein level in both LCL 
FigUre 8 | Proposed model for the protein kinase R (PKR)-dependent nuclear factor erythroid 2-related factor 2 (Nrf2) activation in Leishmania infection. 
Internalized parasite signals through the endosomal compartment via TLR2 and induce activation of PKR by dimerization and subsequent autophosphorylation. 
Subsequently, we found that GSK3 phosphorylation is dependent of PKR signaling, allowing that not occur inhibition of Nrf2 through Neh6 inhibitory domain.  
This activation of Nrf2 is also dependent of Keap1 inhibition through of autophagic and PKR pathways. These mechanisms induce nuclear translocation Nrf2, 
increasing the gene expression of Sod1, Nrf2, and p62. The sequestosome-1 (p62) could be recruiting, together with processed LC3-II and Keap1 for  
autophagic vacuoles, allowing greater Nrf2 activation and inhibition of oxidative stress through antioxidant enzymes.
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and DCL skin biopsies (Figure  6F). These results point to a 
possible compartmentalization of the pathogen-driven immune 
response between tissues in CL, where cutaneous ulcers in LCL 
are exposed to a complex microbiome, which strongly influ-
ences the local immune response, in addition to Leishmania 
antigens (58).
Due to its strong pleiotropic effects and its essential function 
in normal homeostasis, Nrf2 itself is not yet a target of choice 
for therapeutic intervention in LCL. However, this study reiter-
ates our previous suggestion that downstream targets of Nrf2, 
such as Sod1, represent excellent therapeutic targets in LCL. 
Previous works from our and other groups (59–62) have shown 
that the Sod1 inhibitor DETC or its precursor molecule, disul-
firam, are plausible therapeutic alternatives that have been used 
extensively in humans for decades with an excellent safety pro-
file. In conclusion, we demonstrate for the first time the promi-
nent role of Nrf2 and the PKR↔PI3K/Akt↔p62/autophagy 
axis in human and experimental leishmaniasis (Figure  7B). 
Collectively, our data propose a signaling-based scenario that 
may reveal a pivotal molecular basis for CL pathogenesis as well 
as its therapeutic potential. A schematic model based in our 
results is depicted in Figure 8.
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